Insulin glargine Completed Phase 4 Trials for Coronary Artery Disease (CAD) Prevention

Indications	Status	Purpose	Phase
DBCOND0032937 (Coronary Artery Disease (CAD))	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02443402	Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery	Insulin aspart (DB01306) Insulin glargine (DB00047) Insulin human (DB00030) Insulin lispro (DB00046) Sitagliptin (DB01261)